2-Fluoro-6-methyl-3-nitropyridine

We are 2-Fluoro-6-methyl-3-nitropyridine CAS:19346-45-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 2-Fluoro-6-methyl-3-nitropyridine
CAS.NO:19346-45-3
Synonyms:2-Fluor-3-nitro-6-methylpyridin;
2-Fluoro-3-nitro-6-methylpyridine;
2-Fluoro-6-Methyl-3-Nitropyridine;
2-fluoro-3-nitro-6-picoline;
2-fluoro-6-methyl-3-nitro-pyridine;
Molecular Formula:C6H5FN2O2
Molecular Weight:156.11500
 
Physical and Chemical Properties:
Density:1.357 g/mL at 25 °C(lit.)
Melting point:/
Boiling point: 266.2ºC at 760mmHg
Flash point:114.8ºC
Index of Refraction: 1.533
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate

2-Fluoro-6-methyl-3-nitropyridine


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.N- (4-bromofenil) -N-fenil- [1,1'-bifenil] -4-amina CAS:503299-24-9 In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.3-Fluorobenzaldehyde CAS:456-48-4 In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.(9,9-dimethylfluoren-2-yl)boronic acid The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.

Related Products
Product Name
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride View Details
3-Chloro-4-fluorophenylacetic acid View Details
Glutathione View Details
3-Methylpiperidine manufacturer 7-fluoroheptan-1-ol manufacturer N-(2,5-dimethoxyphenyl)-3-oxobutanamide manufacturer (2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane manufacturer 2-Propyl-1H-imidazole-4,5-dicarboxylic acid manufacturer